Skip to content

Gross Profit at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$14.74M+49.4%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$143.88M+16.0%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$134.92M+9.2%
LQD
Liquidia CorporationLQDA
$1.6M+6.5%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Market cap$773.23M+56.4%
Enterprise value$678.78M+30.8%
P/E6.2×
P/S6.3×-5.9×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity-1.5×
Current ratio4.9×+1.9×

Where this comes from

Calculated from Zevra Therapeutics, Inc.’s reported figures.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s gross profit?
Zevra Therapeutics, Inc. (ZVRA) reported gross profit of $34.32M in Q1 2026.
How has Zevra Therapeutics, Inc.'s gross profit changed year-over-year?
Zevra Therapeutics, Inc.'s gross profit increased by 80.1% year-over-year, from $19.06M to $34.32M.
What is the long-term trend for Zevra Therapeutics, Inc.'s gross profit?
Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s gross profit has grown at a 35.6% compound annual growth rate (CAGR), from $26.59M to $89.99M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.